IDEAYA Biosciences (IDYA) Interest Expenses (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Interest Expenses data on file, last reported at $121.5 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 1175.84% year-over-year to $121.5 million; the trailing twelve-month figure through Mar 2026 stood at $121.5 million (up 1175.84% YoY), and the FY2025 full-year result was $196.4 million, up 19.12% from the prior year.
• Interest Expenses grew to $121.5 million in Q1 2026, from $100000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $121.5 million in Q1 2026 to a low of -$1.4 million in Q4 2023.
• A 5-year average of $27.7 million and a median of $9.0 million in 2022 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 91150.0% in 2022 and sank 10321.43% in 2023, its largest moves.
• Tracing IDYA's Interest Expenses over 5 years: stood at $14000.0 in 2022, then slumped by 10321.43% to -$1.4 million in 2023, then jumped by 106.99% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then jumped by 121360.0% to $121.5 million in 2026.
• Business Quant data shows IDYA's Interest Expenses at $121.5 million in Q1 2026, $100000.0 in Q4 2025, and $78.8 million in Q3 2025.